Alumis (NASDAQ: ALMS) experienced a significant stock drop following the failure of its Phase II lupus drug trial. Despite the overall trial setback, positive results in a specific patient su...
Partners Group Holding AG (OTC: PGPHF) Reports Low...
Alarum Technologies Ltd. is set to release it...
Top Market Gainers: SPAC Volatility, Biotech, Geothermal Energy, and AI Stocks Rally Rising Dragon Acquisition Corp. (NASDAQ: RDAC) surged amid continued volatility in the low-float SPAC. bioAffinity
Market Downturn: Alumis (NASDAQ: ALMS) Plunges on Trial Results, Enovis (NYSE: ENOV) Falls After Acquisition Offer, and Leveraged ETFs Decline Alumis Inc. (NASDAQ: ALMS) plunged after its Phase 2b LU
Enovis (NYSE: ENOV) received a revised price target of $27.00 from BMO Capital, suggesting a 24.6% upside despite a recent stock dip. The medical technology company is strategically expanding
Citigroup Reaffirms Buy Rating on NIO (NYSE: NIO) Despite Lower Price Target Citigroup reiterated its “Buy” rating on NIO but lowered its price target to $7.10 from $8.20. NIO’s sec
Yum! Brands recently divested its Pizza Hut division, signaling strategic portfolio adjustments. CEO Christopher Lee Turner executed an insider sale of Yum! Brands shares, a transaction discl
Dell Technologies (NYSE: DELL): Strong Financial Results and AI Server Growth Dell exceeded quarterly revenue and earnings expectations. Its AI server business continues to benefit from strong demand
